X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Strides Arcolab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB STRIDES SHASUN LTD UNICHEM LAB/
STRIDES SHASUN LTD
 
P/E (TTM) x -280.6 32.4 - View Chart
P/BV x 2.1 0.9 239.1% View Chart
Dividend Yield % 1.2 1.1 108.1%  

Financials

 UNICHEM LAB   STRIDES SHASUN LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
STRIDES SHASUN LTD
Mar-17
UNICHEM LAB/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs3201,275 25.1%   
Low Rs221918 24.1%   
Sales per share (Unadj.) Rs167.2389.6 42.9%  
Earnings per share (Unadj.) Rs12.028.0 42.8%  
Cash flow per share (Unadj.) Rs16.948.9 34.6%  
Dividends per share (Unadj.) Rs3.004.50 66.7%  
Dividend yield (eoy) %1.10.4 270.3%  
Book value per share (Unadj.) Rs117.0303.1 38.6%  
Shares outstanding (eoy) m90.8889.42 101.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.62.8 57.5%   
Avg P/E ratio x22.639.2 57.7%  
P/CF ratio (eoy) x16.022.4 71.2%  
Price / Book Value ratio x2.33.6 63.9%  
Dividend payout %25.116.1 155.9%   
Avg Mkt Cap Rs m24,57898,036 25.1%   
No. of employees `0005.25.8 89.5%   
Total wages/salary Rs m2,4875,881 42.3%   
Avg. sales/employee Rs Th2,928.36,005.9 48.8%   
Avg. wages/employee Rs Th479.41,014.0 47.3%   
Avg. net profit/employee Rs Th209.4431.2 48.6%   
INCOME DATA
Net Sales Rs m15,19534,834 43.6%  
Other income Rs m1101,686 6.5%   
Total revenues Rs m15,30536,520 41.9%   
Gross profit Rs m1,7886,428 27.8%  
Depreciation Rs m4521,872 24.1%   
Interest Rs m342,269 1.5%   
Profit before tax Rs m1,4133,973 35.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m0-1,006 0.0%   
Tax Rs m326470 69.3%   
Profit after tax Rs m1,0872,501 43.5%  
Gross profit margin %11.818.5 63.8%  
Effective tax rate %23.111.8 195.0%   
Net profit margin %7.27.2 99.6%  
BALANCE SHEET DATA
Current assets Rs m6,42638,165 16.8%   
Current liabilities Rs m3,91730,402 12.9%   
Net working cap to sales %16.522.3 74.1%  
Current ratio x1.61.3 130.7%  
Inventory Days Days6877 87.5%  
Debtors Days Days77104 73.7%  
Net fixed assets Rs m7,41037,639 19.7%   
Share capital Rs m182894 20.3%   
"Free" reserves Rs m10,45426,210 39.9%   
Net worth Rs m10,63627,105 39.2%   
Long term debt Rs m416,377 0.0%   
Total assets Rs m15,25881,168 18.8%  
Interest coverage x42.92.8 1,560.2%   
Debt to equity ratio x00.6 0.1%  
Sales to assets ratio x1.00.4 232.1%   
Return on assets %7.35.9 125.0%  
Return on equity %10.29.2 110.7%  
Return on capital %13.612.1 112.8%  
Exports to sales %24.10-   
Imports to sales %4.90-   
Exports (fob) Rs m3,666NA-   
Imports (cif) Rs m752NA-   
Fx inflow Rs m5,29813,465 39.3%   
Fx outflow Rs m04,076 0.0%   
Net fx Rs m5,2989,389 56.4%   
CASH FLOW
From Operations Rs m6832,881 23.7%  
From Investments Rs m-1,316-7,051 18.7%  
From Financial Activity Rs m5923,382 17.5%  
Net Cashflow Rs m-40-788 5.1%  

Share Holding

Indian Promoters % 50.1 27.7 180.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 37.8 39.9%  
FIIs % 3.0 8.6 34.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 25.9 122.4%  
Shareholders   20,176 56,241 35.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DISHMAN PHARMA  ELDER PHARMA  VENUS REMEDIES  DR. DATSONS LABS  WOCKHARDT LTD.  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 21, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - FULFORD INDIA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS